Nawal Bendris

Nawal Bendris, PhD has a diverse work experience spanning several pharmaceutical and medical research companies. Nawal began their career as a Postdoctoral Researcher at UT Southwestern Medical Center, where they focused on cancer cell biology and contributed to various scientific publications and grant proposals. Nawal then joined Peloton Therapeutics as a Scientist, playing a pivotal role in supporting clinical and research goals, including the preparation of a phase 3 clinical trial in renal cancer. Peloton Therapeutics was later acquired by a major pharmaceutical company. Afterwards, they joined Merck as a Clinical Scientist, contributing to clinical science activities. Currently, they hold the positions of Senior Clinical Scientist and Associate-Director Clinical Science at Kura Oncology, Inc., where they continue their work in clinical science and leadership in cross-functional teams.

Nawal Bendris, PhD, has an extensive education history in the field of Biology. Nawal began their academic journey at the University of Bejaia, where they pursued a Bachelor of Science (B.Sc.) in Biochemistry and Molecular Biology from 2000 to 2004. Building upon this foundation, Nawal then attended the University of Montpellier in France to further their studies.

From 2005 to 2007, they obtained a Master's degree in Developmental Biology at the University of Montpellier, specializing in this field. Driven by their passion for research, Nawal pursued a Ph.D. in Biology from 2007 to 2011, again at the University of Montpellier. Nawal'sdoctoral studies focused on the intersection of Biology and health.

After completing their Ph.D., Nawal Bendris expanded their expertise through additional certifications. Nawal obtained a Postdoctoral Certificate in Research, though the specific month and year of completion are not provided. This certificate was obtained from the prestigious UT Southwestern Medical Center. Additionally, they obtained a certification in Experimental work with rodents from CNRS-France.

Overall, Nawal Bendris has a strong educational background in Biology, with a Bachelor's degree in Biochemistry and Molecular Biology, a Master's degree in Developmental Biology, and a Ph.D. in Biology with a focus on biology and health. Nawal'scommitment to furthering their knowledge is evident from their additional certifications in research and experimental work with rodents.